<DOC>
	<DOCNO>NCT02704065</DOCNO>
	<brief_summary>End-stage renal disease relate AA amyloidosis well characterize limit data concern patient graft outcomes renal transplantation . The aim study evaluate clinical feature , risk factor recurrent AA amyloidosis , well effect factor ultimate outcome renal allograft .</brief_summary>
	<brief_title>Recurrent AA Amyloidosis After Renal Transplantation</brief_title>
	<detailed_description>AA amyloidosis rare serious complication several chronic inflammatory disease include recurrent hereditary periodic fever syndromes . Although end-stage renal disease relate AA amyloidosis well characterize , limited data concern patient graft outcomes renal transplantation , finding report small series . Recurrence amyloidosis renal allograft might underdiagnosed , assess graft patient outcomes large study group bring well understand new strategy daily practice .</detailed_description>
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>Renal transplantation recipient whose primary renal disease AA amyloidosis ; patient allograft biopsyconfirmed AA amyloidosis ( study group ) patient clinical laboratory sign recurrence renal allograft ( control group 1 ) Renal transplantation recipient whose primary disease AA amyloidosis ( control group 2 ) Patients unwilling unable consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>amyloidosis</keyword>
	<keyword>renal transplantation</keyword>
</DOC>